*Department of Diagnostic Pathology and Cytology

§§Laboratory of Genomic Pathology, Research Center

∥∥Department of Dermatologic Oncology, Osaka International Cancer Institute

**Department of Diagnostic Pathology, Osaka National Hospital, Osaka

†Department of Diagnostic Pathology, Shizuoka Cancer Center Hospital, Sunto

‡Department of Pathology, Tokyo Metropolitan Cancer and Infectious Disease Center Komagome Hospital

∥Department of Pathology, Itabashi Central Clinical Laboratory

¶Department of Anatomic Pathology, Tokyo Medical University, Tokyo

§Department of Dermatology, Hyogo Cancer Center, Akashi

#Department of Diagnostic Pathology, Chutoen General Medical Center, Kakegawa

††Department of Dermato-Oncology/Dermatology, National Hospital Organization Kagoshima Medical Center, Kagoshima

‡‡Department of Dermatology, Shinshu University School of Medicine, Matsumoto, Japan

This study was approved by the Research Ethics Committees of Osaka International Cancer Institute, Osaka, Japan (reference number: 22230), Komagome Hospital, Tokyo, Japan (reference number: 3086), Shizuoka Cancer Center Hospital, Sunto, Japan (reference number: T2023-4), Hyogo Cancer Center, Akashi, Japan (reference number: R22-041), and Shinshu University School of Medicine, Matsumoto, Japan (reference number: 5831).

This work was partly supported by JSPS KAKENHI (Grant Number JP22K06994; Keisuke Goto).

Conflicts of Interest and Source of Funding: The authors have disclosed that they have no significant relationships with, or financial interest in, any commercial companies pertaining to this article.

Correspondence: Keisuke Goto, MD, Department of Diagnostic Pathology and Cytology, Osaka International Cancer Institute, 3-1-69 Ootemae, Chuo-ku, Osaka city, Osaka 541 8567, Japan (e-mail: [email protected]).